WO2002017820A1 - Porous attachment material for cells - Google Patents

Porous attachment material for cells Download PDF

Info

Publication number
WO2002017820A1
WO2002017820A1 PCT/NL2001/000589 NL0100589W WO0217820A1 WO 2002017820 A1 WO2002017820 A1 WO 2002017820A1 NL 0100589 W NL0100589 W NL 0100589W WO 0217820 A1 WO0217820 A1 WO 0217820A1
Authority
WO
WIPO (PCT)
Prior art keywords
attachment material
foam
metal
cells
layer
Prior art date
Application number
PCT/NL2001/000589
Other languages
French (fr)
Inventor
Giles William Melsom
Johannes Arend Mattheus De Waard
Egidius Gerardus Maria Hermsen
Original Assignee
Diocom Beheer B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diocom Beheer B.V. filed Critical Diocom Beheer B.V.
Priority to AU2001294342A priority Critical patent/AU2001294342A1/en
Publication of WO2002017820A1 publication Critical patent/WO2002017820A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/042Iron or iron alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/045Cobalt or cobalt alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30011Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/3092Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30929Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having at least two superposed coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30971Laminates, i.e. layered products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3611Heads or epiphyseal parts of femur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4644Preparation of bone graft, bone plugs or bone dowels, e.g. grinding or milling bone material
    • A61F2002/4648Means for culturing bone graft
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0023Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0023Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
    • A61F2250/0024Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity made from both porous and non-porous parts, e.g. adjacent parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00017Iron- or Fe-based alloys, e.g. stainless steel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00029Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00035Other metals or alloys
    • A61F2310/00131Tantalum or Ta-based alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00185Ceramics or ceramic-like structures based on metal oxides
    • A61F2310/00203Ceramics or ceramic-like structures based on metal oxides containing alumina or aluminium oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00185Ceramics or ceramic-like structures based on metal oxides
    • A61F2310/00239Ceramics or ceramic-like structures based on metal oxides containing zirconia or zirconium oxide ZrO2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00395Coating or prosthesis-covering structure made of metals or of alloys
    • A61F2310/00407Coating made of titanium or of Ti-based alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00796Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite

Definitions

  • the present invention relates to a porous attachment material for cells, in particular bone (cells) , comprising a foam which is metallized with a biocompatible metal or metal alloy, the attachment material having interconnected pores .
  • An attachment material of this type is known, for example from United States Patent US-A-5, 282, 861. This known attachment material is used as a replacement material for spongy (cancellous) bone and/or to receive cells and tissue, since it has a structure which resembles spongy bone of this type, which promotes bone (in) growth.
  • This attachment material is produced by using a chemical vapour deposition method to deposit a biocompatible metal or metal- alloy, in particular tantalum or alloys thereof, on a substrate with a foam structure which is produced, for example, from carbon, graphite or ceramic material. Tantalum is used because it has long been known to have favourable properties for use as an implant material both for bone and tissue.
  • This known attachment material is lightweight, strong, has a porous structure resembling the microstructure which is present in natural spongy bone and acts as a matrix for receiving bone, as well as providing permeability and a high specific surface area to promote the ingrowth of new bone.
  • an insert e.g. from PE
  • the required shape is applied to the implant by further machining operations of the product prior or after compression moulding. This further machining causes struts having an open end to be present, which can raise toxicity problems due to exposure of the bone to carbon.
  • the X-ray permeability of tantalum is relatively weak, which causes diagnostic examination after surgery to be difficult.
  • the foam is a non-carbonized polyurethane foam or polyether foam.
  • foam have a network structure of interconnected pores which can be produced reproducibly.
  • the use of these types of foam for the production of the porous attachment material according to the invention allows metallization techniques which are quicker than CVD to be used. Consequently, the total production costs of the attachment material according to the invention are lower than those of the attachment material according to the above prior art.
  • the network structure of polyurethane foam and that of polyether foam allows the quantity of metal which is deposited to be controlled accurately, so that the porous attachment material according to the invention can also be produced in relatively flexible embodiments .
  • This flexibility allows easy deformation of the attachment material according to the invention.
  • the pore structure of polyurethane foam and that of polyether foam resemble the network structure of the pores in spongy bone, which promotes the growth of cells. It is also possible to control the pore structure of the foam.
  • Polyurethane is preferred to polyether foam with a view to reproducibility.
  • the dimensions of the interconnected pores of the attachment material preferably lie in the range from 50-1000 micrometers.
  • the porosity is preferably in the range from 50-96%.
  • the attachment material has a gradual change in porosity from low porosity, such as 50% or more, for example 70%, to high porosity, such as 96%, as seen in the thickness direction of the attachment material.
  • a gradual change in porosity of this nature leads to a gradual transition between the natural bone and the implant in which the attachment material is used, the side of the attachment material with the highest porosity facing towards the bone and the side with the lowest porosity, which has a relatively dense attachment surface, adjoining, by way of example, a solid section of a prosthesis.
  • the side with the high porosity can be deformed better and therefore adapted to the adjoining bone. At the moment of use during implantation, therefore, there is a large contact area between bone and attachment material and optimum conditions for bone (in) growth are created.
  • the attachment material comprises a dense, non-porous surface layer of the biocompatible metal or metal alloy adjoining the side of low porosity.
  • the attachment material comprises a dense, non-porous surface layer of the biocompatible metal or metal alloy adjoining the side of low porosity.
  • there is a solid surface layer of biocompatible material on one side of the attachment material offering a good attachment surface for a solid part of a prosthesis, for example a prosthesis socket which is made from plastic.
  • the biocompatible metal or metal alloy is preferably selected from the group consisting of Ti, TiNb, TiV, Ta, TaNb, CoCr, CoCrMo and stainless steel, alloys and combinations thereof. Titanium and titanium alloys, such as for example T16A14V are preferred, on account of their proven biocompatibility, as well as their commercial acceptance.
  • the thickness of the porous attachment material is dependent on its use.
  • the thickness of the attachment material is of the order of magnitude of up to 20 mm for cages used in the spinal column, while for other positions and functions the thickness is usually of the order of magnitude of 0.3-4 mm.
  • the attachment material according to the invention may be provided in its pores with an additional upper layer of a calcium- containing and/or phosphate-containing material.
  • HA hydroxyapatite
  • fluoroapatite fluoroapatite
  • TCP tricalcium phosphate
  • OCP octocalcium phosphate
  • brushite a precursor of HA
  • calcium carbonate and the like, which further improve the biocompatibility properties of the attachment material according to the invention.
  • Agents which stimulate bone growth, angiogenesis-stimulating agents, antibacterial agents and/or anti-inflammatories may also be provided in the pores in order to accelerate the growth process of the cells and to prevent infections .
  • a second aspect of the invention provides a method for producing a porous attachment material for cells, in particular bone (cells) , in which a biocompatible metal or metal alloy is applied to the pore walls of a foam, the foam having interconnected pores, which method according to the invention is characterized in that a plastic foam which is selected from a non-carbonized polyurethane foam or polyether foam is used.
  • the attachment material may be produced using a multistage process, in which case in a first step a thin, first starting layer of metal or metal alloy is deposited by means of a physical vapour deposition (PVD) process, and in a second step a thicker layer of the biocompatible metal or metal alloy is deposited by means of an accelerated deposition process, in particular physical vapour deposition processes, such as HS-PVD (high-speed PVD) or LPPS (low- pressure plasma spraying) or EB-PVD.
  • PVD physical vapour deposition
  • the layer thickness of the thin, first starting layer which is deposited using conventional PVD is preferably of the order of magnitude of a few ⁇ m to a few tens of ⁇ m, usually of the order of magnitude of at least 5 ⁇ m.
  • the method according to the invention is preferably carried out as a single-step process, in which the full layer thickness is applied in one operation and in which the settings of a HS-PVD device used for this purpose are adjusted during the process in such a way that a lower energy level is used at the start, in order not to adversely affect the structure of the polyurethane foam, while after a sufficient thickness and strength has been reached the energy level is increased.
  • the initial metal deposit is applied at a low temperature, while after a certain thickness of the metal deposit has been achieved the temperature may be raised and accordingly the deposition rate can be increased.
  • the initial metal deposit protects the foam structure against deterioration.
  • the manufacturing method advantageously comprises a finishing step, wherein a thin layer of a metal or metal alloy, preferably titanium of its alloys, is applied by electroplating.
  • a thin layer of a metal or metal alloy preferably titanium of its alloys
  • an ectroplated finishing layer has an improved smoothness compared to a surface layer deposited by PVD.
  • a thin, first starting layer of metal or metal alloy is deposited by means of a physical vapour deposition process, and in a second step a thicker layer of metal or metal alloy, preferably titanium or its alloys, is electroplated.
  • growth of the initial skeleton and application of a finishing layer is combined.
  • a pyrolysis step may be carried out before or after the second step.
  • the invention provides an implant which is characterized in that at least a section thereof comprises a porous attachment material according to the invention, as described above.
  • implants include, inter alia, a total hip prosthesis, comprising both the femur and acetabulum components, a total knee prosthesis, comprising both the femur and tibia components, a shoulder prosthesis, a finger prosthesis, cages
  • the attachment material according to the invention may be attached to a solid metal part, for example in the shape of a shell, in which a polyethylene insert is immovably positioned, for example by means of diffusion welding or electroplating. Unlike in the prior art, in which the insert is fixedly joined to the attachment material by means of compression moulding, in an implant according to the invention the insert may be exchangeable.
  • the desired strength of the attachment material according to the invention is partly determined by its use. By way of example, the tensile and compressive strengths of trabecular bone are on average 10 MPa.
  • the structure of the porous attachment material according to the invention which does not inherently have a self-regenerating capacity, will have to be stronger than the adjoining bone.
  • the adhesion material according to the invention for load-bearing applications preferably has a tensile strength of more than 20 MPa, a compressive strength of more than 20 MPa, a shearing stress of more than 7 MPa and a Young's modulus of elasticity of 1 GPa.
  • a further aspect of the invention relates to a method for the in-vitro culturing of cells, in particular bone cells, on a substrate in a culture medium, in which a substrate comprising biocompatible material has a foam structure of interconnected pores, and wherein a load is applied periodically or continuously to the substrate.
  • the substrate may be produced from any biocompatible material, provided that it has a structure of interconnected pores.
  • the substrate used is a porous attachment material according to the invention, as described above.
  • cells for example bone marrow or cartilage cells, are cultured in a suitable liquid culture medium which contains the required growth substances, on the substrate.
  • the substrate may be contacted with a reciprocating brush or roller which exerts a stress on the substrate.
  • the cell material obtained can be processed further in various ways.
  • the cell material formed can be removed from the substrate and be introduced immediately into the patient. In this variant, the reproducibility of the network structure of the pores is less important.
  • the cell material formed may also be implanted together with the substrate, in which case the preferred embodiments of the attachment material according to the invention which have been discussed above are advantageously employed for the substrate.
  • the invention provides a porous attachment material for cells, in particular bone (cells) , which attachment material comprises a foam of interconnected pores of a biocompatible material, which is characterized in that the attachment material has a gradual change from low porosity, for example of 50% or more, such as 70%, to a high porosity, such as 96%, as seen in the thickness direction.
  • this gradual change offers a gradual transition between bone and implant, of which the attachment material forms part.
  • the section of low porosity of 50% is provided with a dense, non-porous surface layer of the biocompatible material.
  • Fig. 1 diagrammatically depicts an example of a prosthesis in cross section, in which an attachment material according to the invention is present at various locations; and Fig. 2 shows a detail from Fig. 1.
  • Fig. 1 shows a diagrammatic cross section through a prosthesis, for example a hip or knee prosthesis, which is denoted overall by reference numeral 10, while natural bone is denoted by reference numeral 12.
  • a head 14 of the prosthesis 10 is solid and consists of a biocompatible metal or ceramic, for example CoCrMo, A1 2 0 3 or yttrium- stabilized zirconia.
  • a support part 16 for the head 14 is provided with a layer of attachment material 18 according to the invention.
  • the support part 16 comprises an insert 20 of attachment material according to the invention, which functions as bone substitute, for example when removing a damaged joint surface.
  • a socket 22 of the prosthesis has a layered structure and comprises, from the inside outwards, a polyethylene layer 24, which is in contact with the solid head 14, and a layer 26 of attachment material according to the invention.
  • the layered structure is illustrated in more detail in Fig. 2, using the same reference numerals for the same components.
  • the surface 28 of the attachment layer 26 is provided with a dense surface layer 29 (illustrated in black) and therefore provides a good attachment surface for the polyethylene or ceramic insert 24.
  • the attachment layer 26 has a network structure of interconnected pores, in which the porosity is graduated, from 65% in the vicinity of the surface 28 to 95% on the surface 30 which comes into contact with the bone 12.
  • the starting material used was a commercially available PU foam with an average of 63 pores per inch and with pore dimensions in the range from 400-500 micrometers.
  • the thickness of the PU foam was on average 2 mm.
  • the PU foam was provided in one step with a titanium layer with a layer thickness of 50 micrometers, using conventional PVD. Then, the plastic foam matrix was removed by pyrolysis. By means of a heat treatment under reducing conditions, the titanium foam obtained was brought to its primary ductility. The foam obtained in this way was a flexible attachment material for bone cells which was also eminently suitable as a substrate for the in-vitro culturing of cells.
  • Another piece of the same PU foam was provided, by means of conventional PVD, with a thin layer of titanium with a thickness of 5 micrometers, after which a heat treatment was used to remove the PU matrix by means of pyrolysis, and the titanium foam obtained was brought to its primary ductility by means of a heat treatment. By means of a physical vapour deposition method using HS-PVD, the layer thickness was increased to 50 ⁇ m.
  • the titanium foam thus produced had a porosity, which changed gradually from 65% to 95% on the side closest to the target.
  • the separate pyrolysis step may be omitted.
  • the temperature of the substrate is raised in such a way that pyrolysis occurs automatically.
  • a finishing layer of titanium can be applied by electroplating in order to improve the surface properties of the foam thus produced.

Abstract

A porous attachment material (18; 20; 26) for cells, in particular bone (cells), comprises a foam which is metallized with a biocompatible metal or metal alloy. The attachment material has interconnected pores. According to the invention, the foam is a non-carbonized polyurethane foam or polyether foam. A gradual transition in the porosity increases the possible applications. Attachment material can also be used for the in-vitro culturing of cells.

Description

Porous attachment material for cells
According to a first aspect, the present invention relates to a porous attachment material for cells, in particular bone (cells) , comprising a foam which is metallized with a biocompatible metal or metal alloy, the attachment material having interconnected pores . An attachment material of this type is known, for example from United States Patent US-A-5, 282, 861. This known attachment material is used as a replacement material for spongy (cancellous) bone and/or to receive cells and tissue, since it has a structure which resembles spongy bone of this type, which promotes bone (in) growth. This attachment material is produced by using a chemical vapour deposition method to deposit a biocompatible metal or metal- alloy, in particular tantalum or alloys thereof, on a substrate with a foam structure which is produced, for example, from carbon, graphite or ceramic material. Tantalum is used because it has long been known to have favourable properties for use as an implant material both for bone and tissue. This known attachment material is lightweight, strong, has a porous structure resembling the microstructure which is present in natural spongy bone and acts as a matrix for receiving bone, as well as providing permeability and a high specific surface area to promote the ingrowth of new bone.
One drawback of this known attachment material is its costs on account of the chemical vapour deposition (CVD) technique which is used, and the associated time required. Furthermore, CVD is a rather complex process. To deposit the biocompatible metal or metal alloy in the desired thickness, a long process time is required. In addition, for economic feasibility, it is important for the network structure of the carbon-containing foam to be reproducible. However, US-A- 5,282,861 lacks any details about the production or origin of the foam. This reproducibility leaves something to be desired with many materials, however. Furthermore, this known attachment material is rigid, whereas for many applications a flexible attachment material is preferred with a view to the required shaping. This rigidity is inherent to the step of carbonizing plastic foam which is used in the production of the carbon-containing foam. This carbonization step is required in order to make the foam sufficiently heat-resistant to be able to withstand the temperature of 1100°C which prevails during the CVD of tantalum; otherwise, the original foam would be destroyed at this temperature.
When an implant is to be made, first the attachment material of this kind is to be produced, whereafter an insert, e.g. from PE, is bonded thereto by compression moulding. The required shape is applied to the implant by further machining operations of the product prior or after compression moulding. This further machining causes struts having an open end to be present, which can raise toxicity problems due to exposure of the bone to carbon. The X-ray permeability of tantalum is relatively weak, which causes diagnostic examination after surgery to be difficult.
It is an object of the present invention to at least partially eliminate the abovementioned drawbacks .
For this purpose, in the porous attachment material of the type according to the invention described in the introductory part, the foam is a non-carbonized polyurethane foam or polyether foam. These types of foam have a network structure of interconnected pores which can be produced reproducibly. In addition, the use of these types of foam for the production of the porous attachment material according to the invention allows metallization techniques which are quicker than CVD to be used. Consequently, the total production costs of the attachment material according to the invention are lower than those of the attachment material according to the above prior art. Furthermore, depending on the metallization technique selected, the network structure of polyurethane foam and that of polyether foam allows the quantity of metal which is deposited to be controlled accurately, so that the porous attachment material according to the invention can also be produced in relatively flexible embodiments . This flexibility allows easy deformation of the attachment material according to the invention. Moreover, the pore structure of polyurethane foam and that of polyether foam resemble the network structure of the pores in spongy bone, which promotes the growth of cells. It is also possible to control the pore structure of the foam. Polyurethane is preferred to polyether foam with a view to reproducibility.
The dimensions of the interconnected pores of the attachment material preferably lie in the range from 50-1000 micrometers. The porosity is preferably in the range from 50-96%. These values for the pore dimensions and the porosity of the attachment material according to the invention correspond to the values of the pores in natural bone, so that the attachment material starts to be biologically and mechanically incorporated when used in the body. The lower limit of 50 micrometers for the pore dimensions is determined by the conditions which are required for the formation of new blood vessels, known as angiogenesis.
According to a particularly preferred embodiment, the attachment material has a gradual change in porosity from low porosity, such as 50% or more, for example 70%, to high porosity, such as 96%, as seen in the thickness direction of the attachment material. A gradual change in porosity of this nature leads to a gradual transition between the natural bone and the implant in which the attachment material is used, the side of the attachment material with the highest porosity facing towards the bone and the side with the lowest porosity, which has a relatively dense attachment surface, adjoining, by way of example, a solid section of a prosthesis. Within certain limits, the side with the high porosity can be deformed better and therefore adapted to the adjoining bone. At the moment of use during implantation, therefore, there is a large contact area between bone and attachment material and optimum conditions for bone (in) growth are created.
According to a further variant of this embodiment, the attachment material comprises a dense, non-porous surface layer of the biocompatible metal or metal alloy adjoining the side of low porosity. In other words, there is a solid surface layer of biocompatible material on one side of the attachment material, offering a good attachment surface for a solid part of a prosthesis, for example a prosthesis socket which is made from plastic.
The biocompatible metal or metal alloy is preferably selected from the group consisting of Ti, TiNb, TiV, Ta, TaNb, CoCr, CoCrMo and stainless steel, alloys and combinations thereof. Titanium and titanium alloys, such as for example T16A14V are preferred, on account of their proven biocompatibility, as well as their commercial acceptance.
The thickness of the porous attachment material is dependent on its use. By way of example, the thickness of the attachment material is of the order of magnitude of up to 20 mm for cages used in the spinal column, while for other positions and functions the thickness is usually of the order of magnitude of 0.3-4 mm. For particular applications, for example in oncology, it may be thicker. The attachment material according to the invention may be provided in its pores with an additional upper layer of a calcium- containing and/or phosphate-containing material. Examples of such materials include hydroxyapatite (HA) , fluoroapatite, tricalcium phosphate (TCP) and tetracalcium phosphate, octocalcium phosphate (OCP) , brushite (a precursor of HA) , calcium carbonate, and the like, which further improve the biocompatibility properties of the attachment material according to the invention. Agents which stimulate bone growth, angiogenesis-stimulating agents, antibacterial agents and/or anti-inflammatories may also be provided in the pores in order to accelerate the growth process of the cells and to prevent infections .
A second aspect of the invention provides a method for producing a porous attachment material for cells, in particular bone (cells) , in which a biocompatible metal or metal alloy is applied to the pore walls of a foam, the foam having interconnected pores, which method according to the invention is characterized in that a plastic foam which is selected from a non-carbonized polyurethane foam or polyether foam is used.
The attachment material may be produced using a multistage process, in which case in a first step a thin, first starting layer of metal or metal alloy is deposited by means of a physical vapour deposition (PVD) process, and in a second step a thicker layer of the biocompatible metal or metal alloy is deposited by means of an accelerated deposition process, in particular physical vapour deposition processes, such as HS-PVD (high-speed PVD) or LPPS (low- pressure plasma spraying) or EB-PVD. The layer thickness of the thin, first starting layer which is deposited using conventional PVD is preferably of the order of magnitude of a few μm to a few tens of μm, usually of the order of magnitude of at least 5 μm. Conventional PVD is used to deposit the starting layer, since the quicker methods cannot be used without the risk of damaging or destroying the foam structure of the plastic substrate on account of the high temperatures prevailing. Once a starting layer of sufficient thickness (for example 5 μm) and strength has been deposited, the deposition can be continued, depending on the application varying, for example, from 30 to 1000 μm, with the aid of quicker methods, since the starting layer protects the underlying foam structure of the substrate to a sufficient degree. HS-PVD is preferred, since this technique allows the thickness of the amount of metal deposited on the starting layer which has been formed to be controlled reliably and therefore, if desired, allows a gradual transition in the porosity from high to relatively low to be achieved. The quality and composition of the target used also plays a role in the gradual transition. Other production techniques or combinations, such as electroplating, electroless plating, sputtering, plasma spraying (at low pressure) and sintering are also among the possible options.
With a view to the overall production time, the method according to the invention is preferably carried out as a single-step process, in which the full layer thickness is applied in one operation and in which the settings of a HS-PVD device used for this purpose are adjusted during the process in such a way that a lower energy level is used at the start, in order not to adversely affect the structure of the polyurethane foam, while after a sufficient thickness and strength has been reached the energy level is increased. However, it is not then necessary to interrupt the vacuum. In this preferred embodiment the initial metal deposit is applied at a low temperature, while after a certain thickness of the metal deposit has been achieved the temperature may be raised and accordingly the deposition rate can be increased. In such an embodiment the initial metal deposit protects the foam structure against deterioration.
In order to improve the surface characteristics of the attachment material according to the invention the manufacturing method advantageously comprises a finishing step, wherein a thin layer of a metal or metal alloy, preferably titanium of its alloys, is applied by electroplating. For example, an ectroplated finishing layer has an improved smoothness compared to a surface layer deposited by PVD.
In an alternative embodiment in a first step a thin, first starting layer of metal or metal alloy is deposited by means of a physical vapour deposition process, and in a second step a thicker layer of metal or metal alloy, preferably titanium or its alloys, is electroplated. In this embodiment growth of the initial skeleton and application of a finishing layer is combined. A pyrolysis step may be carried out before or after the second step.
Here it should be noted that in production methods wherein a coating solution containing metal particles is applied at low temperature, a coherent metal structure is obtained by sintering at high temperature. However the increase of the temperature will cause the plastic foam structure to be destroyed before the coherent metal structure has been produced. This is a serious drawback with respect to the final quality of the attachment material thus obtained. In addition, the repeatibility and reproducebility will be low.
According to a further aspect, the invention provides an implant which is characterized in that at least a section thereof comprises a porous attachment material according to the invention, as described above. Examples of implants include, inter alia, a total hip prosthesis, comprising both the femur and acetabulum components, a total knee prosthesis, comprising both the femur and tibia components, a shoulder prosthesis, a finger prosthesis, cages
(intervertebral spacers) , dental/dental surgery implants, soft parts of anchors, and implants for oncology. The attachment material according to the invention may be attached to a solid metal part, for example in the shape of a shell, in which a polyethylene insert is immovably positioned, for example by means of diffusion welding or electroplating. Unlike in the prior art, in which the insert is fixedly joined to the attachment material by means of compression moulding, in an implant according to the invention the insert may be exchangeable. The desired strength of the attachment material according to the invention is partly determined by its use. By way of example, the tensile and compressive strengths of trabecular bone are on average 10 MPa. Since bone has the potential of self-regeneration after traumatic damage, the structure of the porous attachment material according to the invention, which does not inherently have a self-regenerating capacity, will have to be stronger than the adjoining bone. Taking into account a safety margin, the adhesion material according to the invention for load-bearing applications preferably has a tensile strength of more than 20 MPa, a compressive strength of more than 20 MPa, a shearing stress of more than 7 MPa and a Young's modulus of elasticity of 1 GPa.
A further aspect of the invention relates to a method for the in-vitro culturing of cells, in particular bone cells, on a substrate in a culture medium, in which a substrate comprising biocompatible material has a foam structure of interconnected pores, and wherein a load is applied periodically or continuously to the substrate. In this aspect of the invention, the substrate may be produced from any biocompatible material, provided that it has a structure of interconnected pores. Preferably, the substrate used is a porous attachment material according to the invention, as described above. In this method, cells, for example bone marrow or cartilage cells, are cultured in a suitable liquid culture medium which contains the required growth substances, on the substrate. During culturing a load is applied, which is beneficial or even a requirement for the successful growth of cells, in particular bone cells and cartilage cells. For example, the substrate may be contacted with a reciprocating brush or roller which exerts a stress on the substrate. After sufficient cell material has been cultured, the cell material obtained can be processed further in various ways. By way of example, the cell material formed can be removed from the substrate and be introduced immediately into the patient. In this variant, the reproducibility of the network structure of the pores is less important. The cell material formed may also be implanted together with the substrate, in which case the preferred embodiments of the attachment material according to the invention which have been discussed above are advantageously employed for the substrate. According to yet another aspect, the invention provides a porous attachment material for cells, in particular bone (cells) , which attachment material comprises a foam of interconnected pores of a biocompatible material, which is characterized in that the attachment material has a gradual change from low porosity, for example of 50% or more, such as 70%, to a high porosity, such as 96%, as seen in the thickness direction. As stated above, this gradual change offers a gradual transition between bone and implant, of which the attachment material forms part. Better deformation properties and a larger contact area are other advantages. Preferably, the section of low porosity of 50% is provided with a dense, non-porous surface layer of the biocompatible material. The other preferred embodiments described above are also advantageously applied to this aspect of the invention. The invention will be explained below with reference to the appended drawing, in which:
Fig. 1 diagrammatically depicts an example of a prosthesis in cross section, in which an attachment material according to the invention is present at various locations; and Fig. 2 shows a detail from Fig. 1.
Fig. 1 shows a diagrammatic cross section through a prosthesis, for example a hip or knee prosthesis, which is denoted overall by reference numeral 10, while natural bone is denoted by reference numeral 12. A head 14 of the prosthesis 10 is solid and consists of a biocompatible metal or ceramic, for example CoCrMo, A1203 or yttrium- stabilized zirconia. A support part 16 for the head 14 is provided with a layer of attachment material 18 according to the invention. Furthermore, the support part 16 comprises an insert 20 of attachment material according to the invention, which functions as bone substitute, for example when removing a damaged joint surface. A socket 22 of the prosthesis has a layered structure and comprises, from the inside outwards, a polyethylene layer 24, which is in contact with the solid head 14, and a layer 26 of attachment material according to the invention. The layered structure is illustrated in more detail in Fig. 2, using the same reference numerals for the same components. As can be seen from that figure, the surface 28 of the attachment layer 26 is provided with a dense surface layer 29 (illustrated in black) and therefore provides a good attachment surface for the polyethylene or ceramic insert 24. The attachment layer 26 has a network structure of interconnected pores, in which the porosity is graduated, from 65% in the vicinity of the surface 28 to 95% on the surface 30 which comes into contact with the bone 12.
In examples described below for the production of an attachment material according to the invention, the starting material used was a commercially available PU foam with an average of 63 pores per inch and with pore dimensions in the range from 400-500 micrometers. The thickness of the PU foam was on average 2 mm.
The PU foam was provided in one step with a titanium layer with a layer thickness of 50 micrometers, using conventional PVD. Then, the plastic foam matrix was removed by pyrolysis. By means of a heat treatment under reducing conditions, the titanium foam obtained was brought to its primary ductility. The foam obtained in this way was a flexible attachment material for bone cells which was also eminently suitable as a substrate for the in-vitro culturing of cells. Another piece of the same PU foam was provided, by means of conventional PVD, with a thin layer of titanium with a thickness of 5 micrometers, after which a heat treatment was used to remove the PU matrix by means of pyrolysis, and the titanium foam obtained was brought to its primary ductility by means of a heat treatment. By means of a physical vapour deposition method using HS-PVD, the layer thickness was increased to 50 μm. The titanium foam thus produced had a porosity, which changed gradually from 65% to 95% on the side closest to the target.
Depending on the conditions, the separate pyrolysis step may be omitted. In such an embodiment during the second PVD step the temperature of the substrate is raised in such a way that pyrolysis occurs automatically.
A finishing layer of titanium can be applied by electroplating in order to improve the surface properties of the foam thus produced.

Claims

C L I M S
1. Porous attachment material (18; 20; 26) for cells, in particular bone (cells) , comprising a foam which is metallized with a biocompatible metal or metal alloy, the attachment material having interconnected pores, characterized in that the foam is non- carbonized polyurethane foam or polyether foam.
2. Attachment material according to claim 1, characterized in that the dimensions of the interconnected pores lie in the range from 50- 1000 μm.
3. Attachment material according to claim 1 or 2, characterized in that the porosity lies in the range from 50-96%.
4. Attachment material according to one of the preceding claims, characterized in that the attachment material exhibits a gradual change in the porosity, as seen in the thickness direction.
5. Attachment material according to one of the preceding claims, characterized in that a section (28) of low porosity is provided with a dense, non-porous surface layer (29) of the biocompatible metal or metal alloy.
6. Attachment material according to one of the preceding claims, characterized by a porosity which resembles that of a porous bone.
7. Attachment material according to one of the preceding claims, characterized in that the biocompatible metal or metal alloy is selected from the group consisting of Ti, TiNb, TiV, Ta, TaNb, CoCr, CoCrMo and stainless steel, alloys and combinations thereof.
8. Attachment material according to claim 7, characterized in that the biocompatible metal or alloy comprises titanium or a titanium alloy.
9. Attachment material according to one of the preceding claims, characterized by an additional upper layer of a calcium-containing and/or phosphate-containing material in the pores.
10. Attachment material according to one of the preceding claims, characterized in that the attachment material is provided in the pores with one or more agents which stimulate bone growth, angiogenesis-stimulating factors, anti-bacterial agents and/or anti- inflammatories .
11. Method for producing a porous attachment material for cells, in particular bone (cells) , in which a biocompatible metal or metal alloy is applied to the pore walls of a foam, the foam having interconnected pores, characterized in that a plastic foam which is selected from non-carbonized polyurethane foam or polyether foam is used.
12. Method according to claim 11, characterized in that in a first step a thin, first starting layer of metal or metal alloy is deposited by means of a physical vapour deposition process, and in a second step a thicker layer of the metal or metal alloy is deposited by means of an accelerated. deposition process.
13. Method according to claim 11, characterized in that the entire layer thickness is applied in one operation using an accelerated PVD process, work being carried out at a low energy level during a first part of the process, during which a thin, first starting layer of metal or metal alloy is deposited, and then a thicker layer being deposited in a second part at a high energy level.
14. Method according to anyone of claims 11-13, characterized in that the method also comprises a finishing step, wherein a thin layer of metal or metal alloy, preferably titanium or its alloys, is applied by electroplating.
15. Method according to claim 11, characterized in that in a first step a thin, first starting layer of metal or metal alloy is deposited by means of a physical vapour deposition process, and in a second step a thicker layer of a metal or metal alloy, preferably titanium or its alloys, is electroplated.
16. Method according to anyone of claims 12-15, characterized in that the layer thickness of the thin, first starting layer is at least 5 μm.
17. Implant, characterized in that at least a section thereof comprises a porous attachment material according to one of the preceding claims 1-10.
18. Method for culturing cells, in particular bone cells, in vitro, on a substrate in a culture medium, wherein a foam structure of interconnected pores of a biocompatible material is used as the substrate, to which a load is applied.
19. Method according to claim 18, characterized in that a porous attachment material according to one of the preceding claims 1-10 is used as the substrate.
20. Porous attachment material for cells, in particular bone
(cells) , comprising a foam of interconnected pores of a biocompatible material, characterized in that the attachment material has a gradual change in porosity, as seen in the thickness direction.
21. Porous attachment material according to claim 20, characterized in that a section (28) of low porosity is provided with a dense, non- porous surface layer (29) of the biocompatible material.
PCT/NL2001/000589 2000-08-29 2001-08-02 Porous attachment material for cells WO2002017820A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001294342A AU2001294342A1 (en) 2000-08-29 2001-08-02 Porous attachment material for cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1016040 2000-08-29
NL1016040A NL1016040C2 (en) 2000-08-29 2000-08-29 Porous cell attachment material, method for its manufacture, and applications.

Publications (1)

Publication Number Publication Date
WO2002017820A1 true WO2002017820A1 (en) 2002-03-07

Family

ID=19771971

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2001/000589 WO2002017820A1 (en) 2000-08-29 2001-08-02 Porous attachment material for cells

Country Status (3)

Country Link
AU (1) AU2001294342A1 (en)
NL (1) NL1016040C2 (en)
WO (1) WO2002017820A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344537A1 (en) * 2002-02-08 2003-09-17 Howmedica Osteonics Corp. Porous metallic scaffold for tissue ingrowth
FR2883755A1 (en) * 2005-03-29 2006-10-06 Urodelia Sa Implantable material for colonizing bone tissue, comprises titanium, stainless steel, chromium cobalt or tantalum alloy of porous biocompatible metal structure and biodegradable ceramic phosphate placed in-depth of the structure
WO2007016902A2 (en) * 2005-08-06 2007-02-15 M.Pore Gmbh Spongy metallic implant and method for the production thereof
WO2008122595A2 (en) * 2007-04-05 2008-10-16 Cinvention Ag Biodegradable therapeutic implant for bone or cartilage repair
WO2008122596A2 (en) * 2007-04-05 2008-10-16 Cinvention Ag Curable therapeutic implant composition
EP1872745A3 (en) * 2006-06-30 2010-10-06 Howmedica Osteonics Corp. Femoral head resurfacing
WO2012065068A1 (en) * 2010-11-11 2012-05-18 Zimmer, Inc. Orthopedic implant with porous polymer bone contacting surface
EP2517663A1 (en) * 2006-08-22 2012-10-31 Mitsubishi Electric Corporation Laser processing apparatus, osseointegration method, implant material, and implant-material fabrication method
CN102861357A (en) * 2012-10-11 2013-01-09 四川大学 Bionic dental implant and preparation method thereof
FR2986961A1 (en) * 2012-02-20 2013-08-23 Michel Brax ORTHOPEDIC IMPLANT AND METHOD FOR MANUFACTURING SUCH AN ORTHOPEDIC IMPLANT
US8608801B2 (en) * 2008-07-06 2013-12-17 The Trustees Of Columbia University In The City Of New York Osteochondral implants, arthroplasty methods, devices, and systems
DE102014206151A1 (en) * 2014-04-01 2015-10-01 Waldemar Link Gmbh & Co. Kg implant connection
US9949837B2 (en) 2013-03-07 2018-04-24 Howmedica Osteonics Corp. Partially porous bone implant keel

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3030951A (en) * 1959-04-10 1962-04-24 Michael P Mandarino Methods and materials for orthopedic surgery
US4000525A (en) * 1975-08-21 1977-01-04 The United States Of America As Represented By The Secretary Of The Navy Ceramic prosthetic implant suitable for a knee joint plateau
US4154704A (en) * 1978-01-23 1979-05-15 Chemotronics International, Inc. Activated reticulated or unreticulated carbon structures
GB2045082A (en) * 1979-02-15 1980-10-29 Raab S Improved bone connective prosthesis comprising a reinforcement element carrying a polymer layer having a varying modulus of elasticity
US4542539A (en) * 1982-03-12 1985-09-24 Artech Corp. Surgical implant having a graded porous coating
US4553272A (en) * 1981-02-26 1985-11-19 University Of Pittsburgh Regeneration of living tissues by growth of isolated cells in porous implant and product thereof
WO1990006094A1 (en) * 1988-12-08 1990-06-14 Brigham And Women's Hospital Prosthesis of foam and collagen
US4992254A (en) * 1989-12-07 1991-02-12 The United States Of America As Represented By The United States Department Of Energy Low density carbonized composite foams
US5035713A (en) * 1990-02-12 1991-07-30 Orthopaedic Research Institute, Inc. Surgical implants incorporating re-entrant material
DE4106881C1 (en) * 1991-03-05 1992-08-27 Eska Medical Luebeck Medizintechnik Gmbh & Co, 2400 Luebeck, De Implant on which normal bone growth is possible - having its surface partially covered with metallic, partly open-celled structure
US5282861A (en) 1992-03-11 1994-02-01 Ultramet Open cell tantalum structures for cancellous bone implants and cell and tissue receptors
EP0719529A1 (en) * 1994-12-26 1996-07-03 Kyocera Corporation Living body-supporting member and preparation process thereof
WO1999016478A1 (en) * 1997-10-01 1999-04-08 Phillips-Origen Ceramic Technology, Llc Bone substitutes
DE29903768U1 (en) * 1999-03-02 1999-09-09 Plus Endoprothetik Ag Tibial component of a knee endoprosthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2582861A (en) 1948-08-04 1952-01-15 American National Bank A Compa Rotary striping wheel paint striper and adapter for use with collapsible paint tube containers and the like

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3030951A (en) * 1959-04-10 1962-04-24 Michael P Mandarino Methods and materials for orthopedic surgery
US4000525A (en) * 1975-08-21 1977-01-04 The United States Of America As Represented By The Secretary Of The Navy Ceramic prosthetic implant suitable for a knee joint plateau
US4154704A (en) * 1978-01-23 1979-05-15 Chemotronics International, Inc. Activated reticulated or unreticulated carbon structures
GB2045082A (en) * 1979-02-15 1980-10-29 Raab S Improved bone connective prosthesis comprising a reinforcement element carrying a polymer layer having a varying modulus of elasticity
US4553272A (en) * 1981-02-26 1985-11-19 University Of Pittsburgh Regeneration of living tissues by growth of isolated cells in porous implant and product thereof
US4542539A (en) * 1982-03-12 1985-09-24 Artech Corp. Surgical implant having a graded porous coating
WO1990006094A1 (en) * 1988-12-08 1990-06-14 Brigham And Women's Hospital Prosthesis of foam and collagen
US4992254A (en) * 1989-12-07 1991-02-12 The United States Of America As Represented By The United States Department Of Energy Low density carbonized composite foams
US5035713A (en) * 1990-02-12 1991-07-30 Orthopaedic Research Institute, Inc. Surgical implants incorporating re-entrant material
DE4106881C1 (en) * 1991-03-05 1992-08-27 Eska Medical Luebeck Medizintechnik Gmbh & Co, 2400 Luebeck, De Implant on which normal bone growth is possible - having its surface partially covered with metallic, partly open-celled structure
US5282861A (en) 1992-03-11 1994-02-01 Ultramet Open cell tantalum structures for cancellous bone implants and cell and tissue receptors
EP0719529A1 (en) * 1994-12-26 1996-07-03 Kyocera Corporation Living body-supporting member and preparation process thereof
WO1999016478A1 (en) * 1997-10-01 1999-04-08 Phillips-Origen Ceramic Technology, Llc Bone substitutes
DE29903768U1 (en) * 1999-03-02 1999-09-09 Plus Endoprothetik Ag Tibial component of a knee endoprosthesis

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344537A1 (en) * 2002-02-08 2003-09-17 Howmedica Osteonics Corp. Porous metallic scaffold for tissue ingrowth
US7458991B2 (en) 2002-02-08 2008-12-02 Howmedica Osteonics Corp. Porous metallic scaffold for tissue ingrowth
US7740795B2 (en) 2002-02-08 2010-06-22 Howmedica Osteonics Corp. Porous metallic scaffold for tissue ingrowth
FR2883755A1 (en) * 2005-03-29 2006-10-06 Urodelia Sa Implantable material for colonizing bone tissue, comprises titanium, stainless steel, chromium cobalt or tantalum alloy of porous biocompatible metal structure and biodegradable ceramic phosphate placed in-depth of the structure
WO2007016902A2 (en) * 2005-08-06 2007-02-15 M.Pore Gmbh Spongy metallic implant and method for the production thereof
WO2007016902A3 (en) * 2005-08-06 2007-05-18 Pore M Gmbh Spongy metallic implant and method for the production thereof
EP1872745A3 (en) * 2006-06-30 2010-10-06 Howmedica Osteonics Corp. Femoral head resurfacing
US9192418B2 (en) 2006-08-22 2015-11-24 National University Corporation Hokkaido University Laser processing apparatus, osseointegration method, implant material, and implant-material fabrication method
CN102848074A (en) * 2006-08-22 2013-01-02 三菱电机株式会社 Implant-material fabrication method
EP2517663A1 (en) * 2006-08-22 2012-10-31 Mitsubishi Electric Corporation Laser processing apparatus, osseointegration method, implant material, and implant-material fabrication method
WO2008122596A2 (en) * 2007-04-05 2008-10-16 Cinvention Ag Curable therapeutic implant composition
WO2008122596A3 (en) * 2007-04-05 2009-08-06 Cinv Ag Curable therapeutic implant composition
WO2008122595A3 (en) * 2007-04-05 2009-08-06 Cinv Ag Biodegradable therapeutic implant for bone or cartilage repair
WO2008122595A2 (en) * 2007-04-05 2008-10-16 Cinvention Ag Biodegradable therapeutic implant for bone or cartilage repair
US8608801B2 (en) * 2008-07-06 2013-12-17 The Trustees Of Columbia University In The City Of New York Osteochondral implants, arthroplasty methods, devices, and systems
WO2012065068A1 (en) * 2010-11-11 2012-05-18 Zimmer, Inc. Orthopedic implant with porous polymer bone contacting surface
US8998987B2 (en) 2010-11-11 2015-04-07 Zimmer, Inc. Orthopedic implant with porous polymer bone contacting surface
FR2986961A1 (en) * 2012-02-20 2013-08-23 Michel Brax ORTHOPEDIC IMPLANT AND METHOD FOR MANUFACTURING SUCH AN ORTHOPEDIC IMPLANT
WO2013124577A1 (en) * 2012-02-20 2013-08-29 Brax Michel Orthopaedic implant and method for producing such an orthopaedic implant
US9724199B2 (en) 2012-02-20 2017-08-08 Michel Brax Orthopaedic implant and method for manufacturing such an orthopaedic implant
JP2015511842A (en) * 2012-02-20 2015-04-23 ブラクス ミシェル Orthopedic implant and method for manufacturing orthopedic implant
AU2013223905B2 (en) * 2012-02-20 2017-06-22 Michel BRAX Orthopaedic implant and method for producing such an orthopaedic implant
CN102861357A (en) * 2012-10-11 2013-01-09 四川大学 Bionic dental implant and preparation method thereof
CN102861357B (en) * 2012-10-11 2014-06-11 四川大学 Bionic dental implant and preparation method thereof
US9949837B2 (en) 2013-03-07 2018-04-24 Howmedica Osteonics Corp. Partially porous bone implant keel
USD967960S1 (en) 2013-03-07 2022-10-25 Howmedica Osteonics Corp. Porous tibial implant
US11564801B2 (en) 2013-03-07 2023-01-31 Howmedica Osteonics Corp. Partially porous tibial component
DE102014206151A1 (en) * 2014-04-01 2015-10-01 Waldemar Link Gmbh & Co. Kg implant connection

Also Published As

Publication number Publication date
AU2001294342A1 (en) 2002-03-13
NL1016040C2 (en) 2002-03-01

Similar Documents

Publication Publication Date Title
US7648735B2 (en) Oxidized zirconium on a porous structure for bone implant use
EP0560279B1 (en) Open cell tantalum structures for cancellous bone implants and cell and tissue receptors
de Viteri et al. Titanium and titanium alloys as biomaterials
EP2296583B1 (en) Dual-sided joint implant having a wear resistant surface and a bioactive surface
US8268383B2 (en) Medical implant and production thereof
CN111270196B (en) Method for preparing zirconium-niobium alloy surface ceramic oxide layer and application
JPH11341A (en) Orthopedic implant
WO2002017820A1 (en) Porous attachment material for cells
Maehara et al. Application of vanadium-free titanium alloys to artificial hip joints
Srivastav An overview of metallic biomaterials for bone support and replacement
CN110468401A (en) A kind of method that cold spraying prepares porous tantalum bioactivity coatings
Boehm et al. 1.7 Carbon and Diamond
JPH067385A (en) New surface coating for prosthetic material system and prosthetic material system coated therewith
CN106163580B (en) Method for manufacturing a porous metal material for biomedical applications and material obtained by said method
Yao et al. Titanium and cobalt–chromium alloys for hips and knees
EP1710325A1 (en) Method of producing endosseous implants or medical prostheses by means of ionic implantation, and endosseous implant or medical prosthesis thus produced
Xie et al. Deposition and biological evaluation of Ta coating on porous SiC scaffold for orthopedic application
CN114099777A (en) Multi-layer active coating for orthopedic implant and preparation method thereof
RU210800U1 (en) ENDOPROSTHESIS OF THE ACETABULAR COMPONENT OF THE HIP JOINT
RU212589U1 (en) Endoprosthesis of the acetabular component of the hip joint
CN215130919U (en) Acetabular cup with tantalum coating
CN113953515B (en) Biomedical metal porous coating capable of replacing bone cement and preparation method thereof
Goharian et al. Vapor deposition process for osseoconductive surface engineering
Ren Biomaterials and Coatings for Artificial Hip Joints
EP3332745B1 (en) Prosthesis component and method for the production thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP